Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window For children ...
GSK is opening the door to a new era in urinary tract infection (UTI) treatment with its Blujepa, the first in a new class of oral antibiotics for the condition in nearly 30 years. Blujepa, also known ...
First-line antibiotics for uncomplicated urinary tract infection (UTI) remain more effective than fluoroquinolones and beta-lactams, with a 1.78% lower risk for 30-day revisits than fluoroquinolones ...
Earlier research raised concerns about antibiotic use during the first trimester of pregnancy and risk for congenital malformations. In this study, the risk of malformation was higher for infants ...